Biocartis Group NV

ENXTBR:BCART Voorraadrapport

Marktkapitalisatie: €27.2m

Biocartis Group Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Biocartis Group.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Medical Equipment winstgroei19.0%
Inkomstengroein/a
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

None

Laatst bijgewerktn/a

Recente toekomstige groei-updates

Analysts Have Been Trimming Their Biocartis Group NV (EBR:BCART) Price Target After Its Latest Report

Feb 27
Analysts Have Been Trimming Their Biocartis Group NV (EBR:BCART) Price Target After Its Latest Report

Recent updates

Investors Give Biocartis Group NV (EBR:BCART) Shares A 31% Hiding

Jun 17
Investors Give Biocartis Group NV (EBR:BCART) Shares A 31% Hiding

Analysts Have Been Trimming Their Biocartis Group NV (EBR:BCART) Price Target After Its Latest Report

Feb 27
Analysts Have Been Trimming Their Biocartis Group NV (EBR:BCART) Price Target After Its Latest Report

We Think Biocartis Group (EBR:BCART) Has A Fair Chunk Of Debt

Mar 03
We Think Biocartis Group (EBR:BCART) Has A Fair Chunk Of Debt

What Kind Of Shareholders Own Biocartis Group NV (EBR:BCART)?

Jan 27
What Kind Of Shareholders Own Biocartis Group NV (EBR:BCART)?

What We Learned About Biocartis Group's (EBR:BCART) CEO Compensation

Dec 06
What We Learned About Biocartis Group's (EBR:BCART) CEO Compensation

What Can We Learn About Biocartis Group's (EBR:BCART) CEO Compensation?

Sep 01
What Can We Learn About Biocartis Group's (EBR:BCART) CEO Compensation?

What Type Of Returns Would Biocartis Group's(EBR:BCART) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Jul 28
What Type Of Returns Would Biocartis Group's(EBR:BCART) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Biocartis Group onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

ENXTBR:BCART - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/202361-68-51-50N/A
3/31/202359-67-49-47N/A
12/31/202258-65-47-45N/A
9/30/202258-64-53-50N/A
6/30/202259-63-60-56N/A
3/31/202257-67-64-61N/A
12/31/202155-71-69-66N/A
9/30/202158-70-60-57N/A
6/30/202161-69-51-48N/A
3/31/202158-66-47-44N/A
12/31/202056-63-42-39N/A
9/30/202047-64-47-45N/A
6/30/202038-66-51-50N/A
3/31/202038-65-54-52N/A
12/31/201938-64-57-54N/A
9/30/201935-60-56-52N/A
6/30/201933-56-56-50N/A
3/31/201931-52-52-46N/A
12/31/201829-48-48-42N/A
9/30/201829-44-46-41N/A
6/30/201829-40-45-40N/A
3/31/201826-41-45-40N/A
12/31/201723-42-46-41N/A
9/30/201719-46-51-46N/A
6/30/201714-50-56-50N/A
3/31/201714-50N/A-52N/A
12/31/201614-50N/A-53N/A
9/30/201614-48N/A-49N/A
6/30/201614-47N/A-44N/A
3/31/201615-43N/A-36N/A
12/31/201515-40N/A-27N/A
9/30/201515-35N/A-28N/A
6/30/201515-30N/A-28N/A
3/31/201513-29N/A-32N/A
12/31/201410-29N/A-36N/A
12/31/201312-27N/A-41N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if BCART's forecast earnings growth is above the savings rate (1.3%).

Winst versus markt: Insufficient data to determine if BCART's earnings are forecast to grow faster than the Belgian market

Hoge groeiwinsten: Insufficient data to determine if BCART's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if BCART's revenue is forecast to grow faster than the Belgian market.

Hoge groei-inkomsten: Insufficient data to determine if BCART's revenue is forecast to grow faster than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if BCART's Return on Equity is forecast to be high in 3 years time


Ontdek groeibedrijven